Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10445)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Feb 24, 2019 (publication date) through Nov 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Palacios-Eito A, Béjar-Luque A, Rodríguez-Liñán M, García-Cabezas S. Oligometastases in prostate cancer: Ablative treatment. World J Clin Oncol 2019; 10(2): 38-51 [PMID: 30815370 DOI: 10.5306/wjco.v10.i2.38] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v10/i2/38.htm |
| Number | Citing Articles |
| 1 |
Dennis Winkel, Anita M. Werensteijn-Honingh, Petra S. Kroon, Wietse S.C. Eppinga, Gijsbert H. Bol, Martijn P.W. Intven, Hans C.J. de Boer, Louk M.W. Snoeren, Jochem Hes, Bas W. Raaymakers, Ina M. Jürgenliemk-Schulz. Individual lymph nodes: “See it and Zap it”. Clinical and Translational Radiation Oncology 2019; 18: 46 doi: 10.1016/j.ctro.2019.03.004
|
| 2 |
Indrin J. Chetty, Anthony J. Doemer, Jennifer L. Dolan, Joshua P. Kim, Justine M. Cunningham, Jadranka Dragovic, Aharon Feldman, Eleanor M. Walker, Mohamed Elshaikh, Khaled Adil, Benjamin Movsas, Parag J. Parikh. MRI-guided Radiotherapy (MRgRT) for Treatment of Oligometastases: Review of Clinical Applications and Challenges. International Journal of Radiation Oncology*Biology*Physics 2022; 114(5): 950 doi: 10.1016/j.ijrobp.2022.07.027
|
| 3 |
Milap J Shah, Aditya Prakash Sharma, B. M. Zeeshan Hameed, Ravi Jain, Abhijit Patil, Naganathan Karthickeyan, Abhishek Singh. Oligometastatic carcinoma prostate – An overview of the last decade. Indian Journal of Urology 2023; 39(3): 195 doi: 10.4103/iju.iju_60_23
|
| 4 |
Yanmei Li, Jian Chen, Xiaojuan Wang, Pengfei Yang, Jiqin Yang, Qian Zhao, Juan Li. Predictive value of volumetric parameters based on 18F-PSMA-1007 PET/CT for prostate cancer metastasis. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1335205
|
| 5 |
Luke Hilliar, Joshua Wei Liang Yip, Ken Le, Han Loh, Robert Mansberg. Solitary 68Ga-PSMA–Avid Proximal Tibial Prostatic Adenocarcinoma Metastasis Mimicking Enthesopathy. Clinical Nuclear Medicine 2021; 46(1): 81 doi: 10.1097/RLU.0000000000003365
|
| 6 |
Dhruv Bansal, Melissa A. Reimers, Eric M. Knoche, Russell K. Pachynski. Immunotherapy and Immunotherapy Combinations in Metastatic Castration-Resistant Prostate Cancer. Cancers 2021; 13(2): 334 doi: 10.3390/cancers13020334
|
| 7 |
Aileen Green, Peter Temsah, Leonard Goldfarb, Kristen Sanfolippo, Eric Knoche, Razi Muzaffar, Medhat M. Osman. Evaluating appropriateness of 18F-fluciclovine PET/CT relative to standard of care imaging guidelines and the impact of ADT on positivity: a prospective study in 62 Veterans Administration patients at a single institution. Nuclear Medicine Communications 2024; 45(6): 526 doi: 10.1097/MNM.0000000000001836
|
| 8 |
Wei Liu, Katherine Zukotynski, Louise Emmett, Hans T. Chung, Peter Chung, Robert Wolfson, Irina Rachinsky, Anil Kapoor, Ur Metser, Andrew Loblaw, Gerard Morton, Tracy Sexton, Michael Lock, Joelle Helou, Alejandro Berlin, Colm Boylan, Susan Archer, Gregory R. Pond, Glenn Bauman. A Prospective Study of 18F-DCFPyL PSMA PET/CT Restaging in Recurrent Prostate Cancer following Primary External Beam Radiotherapy or Brachytherapy. International Journal of Radiation Oncology*Biology*Physics 2020; 106(3): 546 doi: 10.1016/j.ijrobp.2019.11.001
|
| 9 |
Paul Rogowski, Mack Roach, Nina-Sophie Schmidt-Hegemann, Christian Trapp, Rieke von Bestenbostel, Run Shi, Alexander Buchner, Christian Stief, Claus Belka, Minglun Li. Radiotherapy of oligometastatic prostate cancer: a systematic review. Radiation Oncology 2021; 16(1) doi: 10.1186/s13014-021-01776-8
|
| 10 |
Taketo Kawai, Satoru Taguchi, Keina Nozaki, Naoki Kimura, Takahiro Oshina, Takuya Iwaki, Hotaka Matsui, Aya Niimi, Jun Kamei, Yoshiyuki Akiyama, Yuta Yamada, Yusuke Sato, Daisuke Yamada, Tomoyuki Kaneko, Subaru Sawayanagi, Hidetsugu Nakayama, Ryogo Minamimoto, Hideomi Yamashita, Hideyo Miyazaki, Tetsuya Fujimura, Tohru Nakagawa, Haruki Kume. Prostate-specific antigen doubling time predicts the efficacy of site-directed therapy for oligoprogressive castration-resistant prostate cancer. Prostate International 2023; 11(4): 239 doi: 10.1016/j.prnil.2023.10.002
|
| 11 |
Ewelina Stelcer, Marek Konkol, Aleksandra Głȩboka, Wiktoria Maria Suchorska. Liquid Biopsy in Oligometastatic Prostate Cancer—A Biologist's Point of View. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.00775
|
| 12 |
J. Marzec, J. Becker, F. Paulsen, D. Wegener, S.-C. Olthof, C. Pfannenberg, J. Schwenck, J. Bedke, A. Stenzl, K. Nikolaou, C. la Fougère, D. Zips, A.-C. Müller. 68Ga-PSMA-PET/CT-directed IGRT/SBRT for oligometastases of recurrent prostate cancer after initial surgery. Acta Oncologica 2020; 59(2): 149 doi: 10.1080/0284186X.2019.1669816
|
| 13 |
Katsuyuki Nakanishi, Junichiro Tanaka, Yasuhiro Nakaya, Noboru Maeda, Atsuhiko Sakamoto, Akiko Nakayama, Hiroki Satomura, Mio Sakai, Koji Konishi, Yoshiyuki Yamamoto, Akira Nagahara, Kazuo Nishimura, Satoshi Takenaka, Noriyuki Tomiyama. Whole-body MRI: detecting bone metastases from prostate cancer. Japanese Journal of Radiology 2022; 40(3): 229 doi: 10.1007/s11604-021-01205-6
|
| 14 |
C. Bourgier, I. Latorzeff, P. Fenoglietto, P. Boisselier, M. Charissoux, C. Llacer, C. Lemanski, O. Riou, M.-P. Farcy-Jacquet, D. Azria. Traitement des oligometastases et oligoprogression. Cancer/Radiothérapie 2019; 23(6-7): 482 doi: 10.1016/j.canrad.2019.07.143
|
| 15 |
Nikhil P Mankuzhy, Muayad F Almahariq, Hong Ye, Mitual Amin, Brandon Stone, Daniel J Krauss. Investigation of the Prognostic Significance of Neuroendocrine Differentiation in Gleason Score 7 to 10 Prostate Adenocarcinoma in Patients With Distant Metastasis After Definitive Radiotherapy. American Journal of Clinical Pathology 2021; 155(6): 879 doi: 10.1093/ajcp/aqaa199
|
| 16 |
Abhinav V. Reddy, Matthew N. Mills, Leonid B. Reshko, K. Martin Richardson, Charles R. Kersh. Stereotactic Body Radiation Therapy in Oligometastatic Uterine Cancer: Clinical Outcomes and Toxicity. Cancer Investigation 2020; 38(8-9): 522 doi: 10.1080/07357907.2020.1817483
|
| 17 |
Seo Hee Choi, Seung-Hoon Beom, Young Deuk Choi, Won Sik Ham, Hyunho Han, Woong Kyu Han, Won Sik Jang, Seung Hwan Lee, Jaeho Cho. The Role of Local Prostate and Metastasis-Directed Radiotherapy in the Treatment of Oligometastatic Prostate Cancer. Cancers 2024; 16(18): 3159 doi: 10.3390/cancers16183159
|
| 18 |
Sarah Bergamin, Thomas Eade, Andrew Kneebone, Jeremy Booth, Edward Hsiao, Geoffrey P. Schembri, Kathryn Szymura, Andrew Le, Carol Kwong, Chris Brown, Julia Hunter, George Hruby. Interim Results of a Prospective Prostate-Specific Membrane Antigen-Directed Focal Stereotactic Reirradiation Trial for Locally Recurrent Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics 2020; 108(5): 1172 doi: 10.1016/j.ijrobp.2020.07.014
|
| 19 |
Luke Hilliar, Joshua Wei Liang Yip, Veronica Chi Ken Wong, Ken Le, Robert Mansberg. Solitary Femoral Nodal Metastasis Identified With 68Ga–Prostate-Specific Membrane Antigen PET/CT. Clinical Nuclear Medicine 2021; 46(2): 173 doi: 10.1097/RLU.0000000000003443
|
| 20 |
Yiannis Philippou, Hanna Sjoberg, Alastair D. Lamb, Philip Camilleri, Richard J. Bryant. Harnessing the potential of multimodal radiotherapy in prostate cancer. Nature Reviews Urology 2020; 17(6): 321 doi: 10.1038/s41585-020-0310-3
|
| 21 |
Fabio Matrone, Fabio Del Ben, Marcella Montico, Elena Muraro, Agostino Steffan, Roberto Bortolus, Lucia Fratino, Alessandra Donofrio, Veronica Paduano, Martina Zanchetta, Matteo Turetta, Giulia Brisotto. Prognostic value of circulating tumor cells in oligorecurrent hormone‐sensitive prostate cancer patients undergoing stereotactic body radiation therapy. The Prostate 2024; 84(16): 1468 doi: 10.1002/pros.24787
|
| 22 |
Gustavo A. Viani, Caio V. Arruda, Ana C. Hamamura, Alexandre C. Faustino, Anielle Freitas Bendo Danelichen, Flavio S. Guimarães. Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Recurrence. American Journal of Clinical Oncology 2020; 43(2): 73 doi: 10.1097/COC.0000000000000635
|
| 23 |
Kanta Ka, Papa Macoumba Gaye, Awa Sadikh Badiane, Ibrahima Thiam, Mouhamadou Bachir Ba, Papa Massamba Diene, Maimouna Mané, Lamine Niang, Fatou Samba Ndiaye. Radiotherapy of Oligoprogressive Lesions in Castration-Resistant Prostate Cancer: Impact on Second-Generation Hormone Therapy. Journal of Cancer Therapy 2021; 12(05): 302 doi: 10.4236/jct.2021.125028
|
| 24 |
L. Nicholls, E. Chapman, V. Khoo, Y.-e. Suh, N. Tunariu, Y. Wang, N. van As. Metastasis-directed Therapy in Prostate Cancer: Prognostic Significance of the ESTRO/EORTC Classification in Oligometastatic Bone Disease. Clinical Oncology 2022; 34(1): 63 doi: 10.1016/j.clon.2021.10.004
|
| 25 |
Riccardo Vigna-Taglianti, Alberto Boriano, Anna Maria Merlotti, Stefania Martini, Stefania Martini, Gianello Luca, Salvatore Solla, Spinelli Lavinia, Francesco Olivero, Fabrizio Bergesio, Adriano De Maggi, Alessia Reali, Elvio Grazioso Russi. Long Term Results of Elective Nodal Salvage Radiotherapy in Oligometastatic Prostate Cancer : A Mono-Institutional Series. annals of urologic oncology 2022; doi: 10.32948/auo.2022.09.30
|
| 26 |
Ryo Oka, Takanobu Utsumi, Takahide Noro, Yuta Suzuki, Shota Iijima, Yuka Sugizaki, Takatoshi Somoto, Seiji Kato, Takumi Endo, Naoto Kamiya, Hiroyoshi Suzuki. Progress in Oligometastatic Prostate Cancer: Emerging Imaging Innovations and Therapeutic Approaches. Cancers 2024; 16(3): 507 doi: 10.3390/cancers16030507
|